Aliases & Classifications for Pericarditis

MalaCards integrated aliases for Pericarditis:

Name: Pericarditis 12 54 43 15 62 17 71

Classifications:



External Ids:

Disease Ontology 12 DOID:1787
MeSH 43 D010493
NCIt 49 C34915
SNOMED-CT 67 3238004
ICD10 32 I32 I32.8
UMLS 71 C0031046

Summaries for Pericarditis

PubMed Health : 62 About pericarditis: Pericarditis (PER-ih-kar-DI-tis) is a condition in which the membrane, or sac, around your heart is inflamed. This sac is called the pericardium (per-ih-KAR-de-um). The pericardium holds the heart in place and helps it work properly. The sac is made of two thin layers of tissue that enclose your heart. Between the two layers is a small amount of fluid. This fluid keeps the layers from rubbing against each other and causing friction.

MalaCards based summary : Pericarditis is related to constrictive pericarditis and pericardial tuberculosis, and has symptoms including chest pain An important gene associated with Pericarditis is PRG4 (Proteoglycan 4), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Oseltamivir and Coal tar have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and liver, and related phenotypes are homeostasis/metabolism and hematopoietic system

Disease Ontology : 12 A pericardium disease that is characterized by an inflammation of the pericardium and has symptom chest pain.

Wikipedia : 74 Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms... more...

Related Diseases for Pericarditis

Diseases related to Pericarditis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1176)
# Related Disease Score Top Affiliating Genes
1 constrictive pericarditis 34.8 NPPB IFNG CRP ADA
2 pericardial tuberculosis 34.1 IFNG CRP ADA
3 idiopathic recurrent pericarditis 33.9 TNFRSF1A RETN MEFV LEP ADIPOQ
4 systemic onset juvenile idiopathic arthritis 33.1 TNF IL1B
5 juvenile arthritis 33.0 IL6 CXCL8 CRP
6 drug reaction with eosinophilia and systemic symptoms 32.7 TNF CRP
7 cardiac tamponade 32.1 TNFRSF1A NPPB CRP ADA
8 pericardial effusion 32.0 TNFRSF1A NPPB IL6 CRP ADA
9 systemic lupus erythematosus 32.0 TNFRSF1A TNF IL6 IL1B IFNG CXCL8
10 myocarditis 31.4 TNF NPPB IL6 IL1B IFNG
11 endocarditis 31.3 TNF IL6 IFNG CXCL8 CRP
12 vasculitis 31.2 TNF MEFV IL6 CRP
13 haemophilus influenzae 31.2 VTN TNF CXCL8
14 infective endocarditis 31.1 TNNT2 TNF IL6 CRP
15 enthesopathy 31.1 TNF MEFV CRP
16 congestive heart failure 31.0 TNNT2 TNF NPPB IL6 IL1B CRP
17 cardiogenic shock 31.0 NPPB CRP
18 mitral valve insufficiency 31.0 TNNT2 NPPB CRP
19 acute myocardial infarction 31.0 TNNT2 TNF NPPB IL6 CRP
20 q fever 30.9 TNF IL6 IL1B IFNG
21 pleurisy 30.9 TNF MEFV IFNG CXCL8 CRP ADA
22 end stage renal disease 30.8 TNF IL6 CRP ADIPOQ
23 colitis 30.8 TNF IL6 IL1B IFNG CXCL8
24 chickenpox 30.8 TNF IL6 IFNG CRP ADA
25 mycobacterium tuberculosis 1 30.8 TNFRSF1A TNF IFNG CRP ADA
26 nocardiosis 30.8 TNF IFNG CRP
27 sarcoidosis 1 30.8 TNF IL1B IFNG CRP ADA
28 arthropathy 30.8 TNF PRG4 IL6 IL1B IFNG CRP
29 pancreatitis 30.7 TNF IL6 IL1B CRP
30 uremia 30.7 TNF RETN LEP IL6 CRP
31 herpes zoster 30.7 TNF IFNG CRP
32 angina pectoris 30.7 NPPB IL6 CRP ADIPOQ
33 rheumatic fever 30.7 TNF NPPB IL6 IFNG
34 influenza 30.7 TNF IL6 IL1B IFNG CXCL8
35 cardiac rupture 30.7 TNF CXCL8 CRP
36 atrial fibrillation 30.7 TNNT2 NPPB IL6 CRP
37 echinococcosis 30.7 TNF IL6 IFNG
38 rheumatic heart disease 30.7 TNF NPPB IL6 IL1B
39 osteomyelitis 30.7 TNF IL6 IL1B IFNG CXCL8
40 acute myocarditis 30.7 TNNT2 TNF NPPB IL1B CRP
41 brucellosis 30.7 TNF MEFV IL6 IFNG CXCL8 CRP
42 ulcerative colitis 30.7 TNF IL6 IL1B IFNG CXCL8 CRP
43 miliary tuberculosis 30.7 TNF IFNG CRP ADA
44 melioidosis 30.6 TNF IL6 IFNG
45 pulmonary tuberculosis 30.6 TNF IL6 IL1B IFNG CRP ADA
46 familial mediterranean fever 30.6 TNFRSF1A TNF MEFV IL6 IL1B CXCL8
47 polyarteritis nodosa 30.6 MEFV IL6 CRP
48 heart aneurysm 30.6 TNF IL6 CRP
49 connective tissue disease 30.6 TNF IL6 IL1B IFNG CXCL8 CRP
50 extrapulmonary tuberculosis 30.6 TNF IL1B IFNG CRP ADA

Graphical network of the top 20 diseases related to Pericarditis:



Diseases related to Pericarditis

Symptoms & Phenotypes for Pericarditis

Symptoms:

12
  • chest pain

MGI Mouse Phenotypes related to Pericarditis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.28 ADA ADIPOQ CRP IFNG IL1B IL6
2 hematopoietic system MP:0005397 10.21 ADA ADIPOQ IFNG IL1B IL6 IRAK4
3 cardiovascular system MP:0005385 10.2 ADA ADIPOQ CRP IFNG IL1B IL6
4 immune system MP:0005387 10.18 ADA ADIPOQ CRP IFNG IL1B IL6
5 integument MP:0010771 9.97 ADIPOQ IFNG IL1B IL6 LEP MEFV
6 liver/biliary system MP:0005370 9.91 ADA ADIPOQ IFNG IL6 LEP MEFV
7 muscle MP:0005369 9.76 ADA ADIPOQ IFNG IL6 LEP TNF
8 neoplasm MP:0002006 9.5 ADIPOQ IFNG IL1B IL6 LEP TNF
9 respiratory system MP:0005388 9.23 ADA ADIPOQ IFNG IL6 LEP TNF

Drugs & Therapeutics for Pericarditis

PubMed Health treatment related to Pericarditis: 62

Most cases of pericarditis are mild; they clear up on their own or with rest and simple treatment . Other times, more intense treatment is needed to prevent complications. Treatment may include medicines and, less often, procedures or surgery . The goals of treatment include: Reducing pain and inflammation Treating the underlying cause, if it's known Checking for complications

Drugs for Pericarditis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 86)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oseltamivir Approved Phase 4 204255-11-8, 196618-13-0 65028
2
Coal tar Approved Phase 4 8007-45-2
3
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
4
Ibuprofen Approved Phase 4 15687-27-1 3672
5
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
6 Antiviral Agents Phase 4
7 Vaccines Phase 4
8 Immunoglobulins Phase 4
9 Antibodies Phase 4
10 Rho(D) Immune Globulin Phase 4
11 gamma-Globulins Phase 4
12 Immunoglobulins, Intravenous Phase 4
13 Antiemetics Phase 4
14 Gastrointestinal Agents Phase 4
15
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
16
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
17
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
18
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
19 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
20
Streptokinase Approved, Investigational Phase 3 9002-01-1
21
Nitroglycerin Approved, Investigational Phase 3 55-63-0 4510
22
Trastuzumab Approved, Investigational Phase 3 180288-69-1 9903
23
Ramipril Approved Phase 3 87333-19-5 5362129
24
Bisoprolol Approved Phase 3 66722-44-9 2405
25
Deferoxamine Approved, Investigational Phase 2, Phase 3 70-51-9 2973
26
Hydroxyurea Approved Phase 2, Phase 3 127-07-1 3657
27
Iron Approved, Experimental Phase 2, Phase 3 15438-31-0, 7439-89-6 27284 23925
28
Deferasirox Approved, Investigational Phase 2, Phase 3 201530-41-8 5493381
29
carbamide peroxide Approved Phase 2, Phase 3 124-43-6
30
Rilonacept Approved, Investigational Phase 3 501081-76-1 104924
31
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
32 Methylprednisolone Acetate Phase 3
33 Pharmaceutical Solutions Phase 3
34 Adrenergic beta-Antagonists Phase 3
35 Adrenergic beta-1 Receptor Antagonists Phase 3
36 Adrenergic Antagonists Phase 3
37 Angiotensin-Converting Enzyme Inhibitors Phase 3
38 Antihypertensive Agents Phase 3
39 Sympatholytics Phase 3
40 Adrenergic Agents Phase 3
41
protease inhibitors Phase 3
42 HIV Protease Inhibitors Phase 3
43 Neurotransmitter Agents Phase 3
44 Antioxidants Phase 2, Phase 3
45 Chelating Agents Phase 2, Phase 3
46 Omega 3 Fatty Acid Phase 2, Phase 3
47 Nigella Phase 2, Phase 3
48 Iron Chelating Agents Phase 2, Phase 3
49
Eplerenone Approved Phase 2 107724-20-9 150310 443872
50
Atorvastatin Approved Phase 2 134523-00-5 60823

Interventional clinical trials:

(show top 50) (show all 82)
# Name Status NCT ID Phase Drugs
1 Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled,Clinical Study. Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
2 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis. Completed NCT00235079 Phase 4 Colchicine;Placebo
3 AnakInRa for Treatment of Recurrent Idiopathic Pericarditis Completed NCT02219828 Phase 4 Anakinra;Placebo
4 Cochicine Treatment for Post- Operative Pericardial Effusion: The POPE 2 Study A Multicenter, Double-blind, Randomized Trial Completed NCT01266694 Phase 4 Colchicines;Placebo
5 Vaccinia Vaccination (ACAM2000®) of Plasma Donors for the Production of Vaccinia Immune Globulin Intravenous (VIGIV) Recruiting NCT02443623 Phase 4
6 Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention: Inflammatory Marker Substudy of the Colchicine-PCI Trial Active, not recruiting NCT01709981 Phase 4 Colchicine;Placebo
7 Dexamethasone Compared to Conventional Therapy in the Treatment of Acute Pericarditis: a Superiority Randomized Controlled Trial (Dexa-P) Not yet recruiting NCT04323280 Phase 4 Dexamethasone therapy;Conventional Therapy
8 Benign Acute Pericarditis: Brief Versus Longer Treatment. Randomized, Multicentric, Double Blind, Non Inferiority Trial Terminated NCT00946907 Phase 4 Aspirin;placebo
9 A Trial of Complete Percutaneous Pericardial Drainage Facilitated by Intrapericardial Alteplase Compared to Conventional Pericardiocentesis When Indicated in Adults With Large Pericardial Effusion Due to Tuberculous and Non-tuberculous Pericarditis Unknown status NCT02673879 Phase 3
10 Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection Unknown status NCT02787382 Phase 3
11 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The ICAP Trial: Investigation on Colchicine for Acute Pericarditis Completed NCT00128453 Phase 3 Colchicine (for 3 months);Placebo
12 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP Trial: COlchicine for Recurrent Pericarditis Completed NCT00128414 Phase 3 Colchicine (for 6 months);Placebo
13 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The COPPS Trial: COlchicine for the Prevention of Postpericardiotomy Syndrome Completed NCT00128427 Phase 3 Colchicine (for 1 month)
14 A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis Completed NCT00810849 Phase 3 Prednisolone
15 Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Completed NCT01373281 Phase 3
16 A Prospective Phase III Parallel, Randomised Controlled Trial Using Double-bolus Recombinant Staphylokinase (THR-100) vs Streptokinase in Patients With Acute Myocardial Infarction Completed NCT01305226 Phase 3 THR-100;Streptokinase
17 Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis? Completed NCT00121901 Phase 3 glyceryl nitrate
18 Colchicine in Postoperative Fontan Patients (CPFP) Recruiting NCT03575572 Phase 2, Phase 3 Colchicine
19 Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo)Adjuvant Anthracyclines and/or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial Recruiting NCT02236806 Phase 3 Bisoprolol;Ramipril;Placebo
20 Impact of Combination Therapy Between Hydroxy Urea, Omega 3, Nigella Sativa and Honey on Antioxidant-oxidant Status and Reduction of Iron Overload in Pediatric Major Thalassemia Recruiting NCT04292314 Phase 2, Phase 3 Omega 3;Nigella Sativa Oil;Hydroxyurea;Honey;Deferoxamine
21 Phase 3, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study With Open-label Extension, to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis Active, not recruiting NCT03737110 Phase 3 Rilonacept;Placebo
22 Colchicine Versus Placebo in Post-Cardiac Surgery Patients to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation Terminated NCT02177266 Phase 3 Colchicine;Placebo
23 A Randomized, Prospective Double Blind Placebo Control Clinical Trial of Prednisone as Adjunctive Therapy for the Treatment of Hospitalized Patients With Pulmonary TB and HIV Co-infection Withdrawn NCT00414414 Phase 3 Prednisone;placebo
24 An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis Completed NCT03980522 Phase 2 KPL-914
25 Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response Completed NCT02363725 Phase 2 Colchimax®;Conventional treatment
26 A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept vs Placebo on a Background of Oral Glucocorticosteroids in the Treatment of Subjects With Systemic Lupus Erythematosus and the Prevention of Subsequent Lupus Flares Completed NCT00119678 Phase 2 Abatacept;Placebo;Prednisone;Abatacept
27 A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer Completed NCT00581256 Phase 1, Phase 2
28 Randomized, Double-Blind, Placebo-Controlled Trial if IL1-TRAP, Rilonacept, in Systemic Sclerosis -A Phase I/II Biomarker Trial Completed NCT01538719 Phase 1, Phase 2 Rilonacept
29 A Randomised, Double Blind Pilot Study of Minocycline and Placebo Added to Treatment-as-Usual (TAU) in First-Episode Psychosis Completed NCT00916461 Phase 1, Phase 2 Minocycline;Placebo
30 A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT) Dose Escalation in the Treatment of Patients With Inoperable Stage I/II Non-Small Cell Lung Cancer Arising Within the Zone of the Proximal Bronchial Tree Completed NCT00591838 Phase 1, Phase 2
31 Randomized Phase I/II Study of Ablative Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer Recruiting NCT03148327 Phase 1, Phase 2 Durvalumab (MEDI 4736)
32 Treatment of Acute Pericarditis With Anakinra Active, not recruiting NCT03224585 Phase 2 Anakinra;Placebo
33 Phase II, Randomised, Multicentre Study With Two Treatment Arms (R-COMP Versus R-CHOP) in Newly Diagnosed Elderly Patients (≥60 Years) With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb. Active, not recruiting NCT02012088 Phase 2 RCOMP;RCHOP
34 A Randomized, Double-Blind Placebo-Controlled Study of 3,5-diiodothyropropionic Acid (DITPA) in Combination With Standard Therapy to Attain NCEP ATP III Goal for LDL Cholesterol in Hypercholesterolemic Patients Terminated NCT00311987 Phase 1, Phase 2 3,5-Diiodothyropropionic acid (DITPA) therapy
35 Dose-Ranging, Safety And Efficacy Of Cathflo(TM) Activase(R) (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I Terminated NCT00265005 Phase 1 alteplase
36 Phase 1 Study to Assess the Safety of 500mg of Aspirin Added to IV TPA at Standard Doses to Prevent Re-occlusion of Cerebral Vessels After Successful Reperfusion. Withdrawn NCT00417898 Phase 1 Aspirin
37 Clinical Audit of the Management of Pericarditis in Children. Unknown status NCT03253315
38 Improvement of the Etiological Diagnosis of the Pericarditis Unknown status NCT02828085
39 Noise of Airplanes a Factor of Risk for the Health of the Heart in Pilots and Crew in Operations of the F16 Airplane Unknown status NCT01063582
40 Safety of a Early Discharge Strategy in Patients With Low-risk ST-segment Elevation Myocardial Infarction Treated With Primary Coronary Intervention: a Randomized Controlled Trial Unknown status NCT01868256
41 Transient ECG Changes in Patients With Acute Biliary Disease Unknown status NCT01706068
42 Influence of a Rehabilitation Nursing Care Program on Quality of Life of Patients Undergoing Cardiac Surgery Unknown status NCT03517605
43 Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis Unknown status NCT02488200
44 A Randomised Controlled Trial of Oxygen Therapy in Acute Myocardial Infarction (AVOID - Air Verses Oxygen In myocarDial Infarction Study) Unknown status NCT01272713
45 ST Elevation (Acute Coronary Syndrome Versus Pericarditis;Could Measurement of Lp-associated PLA2 -a Vascular Specific Marker of Inflammation- be Helpful to the Clinician? Completed NCT01041339
46 ACAM2000® Myopericarditis Registry Completed NCT01395082
47 A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel Completed NCT00927719
48 Epipericardial Fat Necrosis: A Misdiagnosed Condition Completed NCT01903980
49 A Translational Study to Understand the Mechanism of Apolipoprotein CIII Reduction Via Colchicine Completed NCT02083510 Early Phase 1 Colchicine
50 Retrospective Review of Cardiomyopathy Patient Cases Post Allogeneic Hematopoietic Stem Cell Transplantation Completed NCT00352209

Search NIH Clinical Center for Pericarditis

Cochrane evidence based reviews: pericarditis

Genetic Tests for Pericarditis

Anatomical Context for Pericarditis

MalaCards organs/tissues related to Pericarditis:

40
Heart, Lung, Liver, Breast, Testes, Kidney, Bone

Publications for Pericarditis

Articles related to Pericarditis:

(show top 50) (show all 11452)
# Title Authors PMID Year
1
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. 54 61
20074469 2009
2
Tuberculous pericarditis. 54 61
16330703 2005
3
Adenosine deaminase activity--more than a diagnostic tool in tuberculous pericarditis. 61 54
16049586 2005
4
Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. 54 61
16218464 2005
5
The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. 54 61
9479590 1997
6
The exudative-constrictive tuberculosis pericarditis diagnosed by toracoscopic biopsy. 61
32462083 2020
7
Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis. 61
32416963 2020
8
Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. 61
32312616 2020
9
The Treatment of Acute Rheumatic Fever: Novel Use of Hydroxychloroquine. 61
32221169 2020
10
Nontuberculous extensive constrictive pericarditis calcarea impairing right ventricular filling in an HIV-infected patient: the key role of computed tomography imaging. 61
32251076 2020
11
Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children. 61
32546242 2020
12
Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery. 61
32407676 2020
13
Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model. 61
32554248 2020
14
Is There a Brain/Heart Interaction in Rheumatoid Arthritis and Seronegative Spondyloartropathies? A Combined Brain/Heart Magnetic Resonance Imaging Reveals the Answer. 61
32562092 2020
15
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus. 61
32573428 2020
16
Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population. 61
32356674 2020
17
Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes. 61
32562022 2020
18
Kawasaki disease: Shedding light on a mysterious diagnosis. 61
32520905 2020
19
Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease. 61
31745825 2020
20
Causes of swine polyserositis in a high-density breeding area in Italy. 61
32495719 2020
21
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation. 61
32549293 2020
22
Acute pericarditis secondary to COVID-19. 61
32395943 2020
23
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. 61
32227076 2020
24
Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. 61
32306491 2020
25
Pericardial Effusion and Tamponade Complicating Acute Pericarditis in a Human Metapneumovirus-Infected Adult: A Unique Case Report. 61
32528782 2020
26
Epicardial Interventions: Impact of Liposomal Bupivacaine on Postprocedural Management (The EPI-LIBRE Study). 61
32496820 2020
27
Delayed cardiac tamponade from pericarditis following pulmonary vein cryo-balloon ablation. 61
32537931 2020
28
[Cardiac Tamponade as Cardio-Oncologic Emergency Disease]. 61
32541160 2020
29
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study. 61
31610707 2020
30
[Safety and efficiency of interventional electrophysiology utilizing the German "Belegarztsystem"]. 61
32372229 2020
31
Stork leg sign in acute pericarditis. 61
32491300 2020
32
Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020. 61
32562029 2020
33
Expanding the evidence for effective therapies in recurrent pericarditis. 61
31787024 2020
34
Predictors of postoperative complication and prolonged intensive care unit stay after complete pericardiectomy in tuberculous constrictive pericarditis. 61
32560663 2020
35
Chest and Back Pain. 61
32291089 2020
36
A collective European experience with left atrial appendage suture ligation using the LARIAT+ device. 61
32044994 2020
37
The transcriptional regulator PhoP mediates the tolC molecular mechanism on APEC biofilm formation and pathogenicity. 61
31809574 2020
38
Cryptococcal pericarditis in a heart transplant recipient. 61
32533755 2020
39
Prognostic importance of mitral e' velocity in constrictive pericarditis. 61
32514577 2020
40
The presence of P2RX7 single nuclear polymorphism is associated with a gain of function in P2X7 receptor and inflammasome activation in SLE complicated with pericarditis. 61
31376246 2020
41
Diagnostic performance of interferon-gamma release assay for diagnosis of tuberculous pericarditis: A meta-analysis. 61
31927772 2020
42
Onset of idiopathic recurrent pericarditis during pregnancy: successful management with colchicine and intravenous immunoglobulins. 61
32040030 2020
43
Pericardiobiliary fistula causing acute pericarditis and tamponade following extensive cytoreductive surgery. 61
31578756 2020
44
Editorial commentary: Recurrent pericarditis in the era of interleukin-1 inhibition. 61
32417368 2020
45
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment. 61
32376492 2020
46
Constrictive Pericarditis After Lung Transplantation. 61
31478992 2020
47
Hemodynamics of constrictive pericarditis and restrictive cardiomyopathy. 61
31904891 2020
48
[Value of left ventricular myocardial strain derived from cardiac magnetic resonance tissue tracking on differentiating constrictive pericarditis from restrictive cardiomyopathy]. 61
32450655 2020
49
[A perimyocarditis revealing eosinophilic granulomatosis with polyangiitis]. 61
32265026 2020
50
Pharmacotherapeutic Management Strategies for Thyroid Disease-Induced Pericarditis. 61
31744311 2020

Variations for Pericarditis

Expression for Pericarditis

Search GEO for disease gene expression data for Pericarditis.

Pathways for Pericarditis

Pathways related to Pericarditis according to GeneCards Suite gene sharing:

(show top 50) (show all 71)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.08 VTN TNFRSF1A TNF RETN MEFV IRAK4
2
Show member pathways
13.39 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
3
Show member pathways
13.33 TNFRSF1A TNF NPPB LEP IL6 IL1B
4
Show member pathways
13.1 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
5
Show member pathways
12.98 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
6
Show member pathways
12.88 TNF IL6 IL1B IFNG CXCL8
7
Show member pathways
12.87 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
8 12.85 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
9
Show member pathways
12.83 TNFRSF1A TNF RETN LEP IL6 ADIPOQ
10
Show member pathways
12.76 TNF IRAK4 IL6 IL1B CXCL8
11
Show member pathways
12.75 TNFRSF1A TNF IRAK4 IL6 IL1B
12
Show member pathways
12.71 TRAF3IP2 TNFRSF1A TNF IL1B IFNG
13 12.62 TNFRSF1A TNF IRAK4 IL1B IFNG
14 12.42 TNFRSF1A TNF IL1B CXCL8
15
Show member pathways
12.39 TNF IL6 IL1B IFNG CRP
16
Show member pathways
12.38 TNF IRAK4 IL6 IL1B IFNG CXCL8
17
Show member pathways
12.38 TRAF3IP2 TNF IL6 IL1B IFNG CXCL8
18
Show member pathways
12.37 TNFRSF1A TNF IL6 CXCL8
20 12.33 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
21
Show member pathways
12.32 TNFRSF1A TNF IRAK4 IL1B IFNG
22
Show member pathways
12.31 TNF IRAK4 IL6 CXCL8
23
Show member pathways
12.31 TNF IL6 IL1B IFNG CXCL8
24 12.27 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
25
Show member pathways
12.25 TNFRSF1A TNF IL1B IFNG
26 12.24 TNFRSF1A TNF IL6 IFNG
27 12.23 TNF MEFV IRAK4 IL6 IL1B CXCL8
28 12.22 TNF IL6 IL1B CXCL8
29 12.21 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
30 12.14 TNFRSF1A TNF IL1B IFNG
31 12.14 TNF RETN LEP IL6 ADIPOQ
32 12.1 TNFRSF1A TNF IL1B IFNG
33
Show member pathways
12.1 TNF IRAK4 IL6 IL1B IFNG CXCL8
34 12.04 TNF IL6 IL1B CXCL8
35 12.03 TNFRSF1A TNF IL6 IL1B
36 12.01 VTN IL6 IL1B IFNG CXCL8
37
Show member pathways
12 TNF IL6 IL1B IFNG
38 12 TNFRSF1A TNF IRAK4 IL1B CXCL8
39 11.98 TNF IL6 IL1B IFNG CXCL8
40 11.96 TNF IL6 IL1B CXCL8
41 11.94 TNNT2 LEP IL6 ADIPOQ
42 11.91 TNF IL6 IL1B IFNG CXCL8
43 11.83 IL6 IFNG CXCL8
44 11.82 TNF IL1B IFNG
45 11.82 TNF IL6 IL1B IFNG
46
Show member pathways
11.79 TNF IFNG CXCL8
47 11.78 TNFRSF1A TNF LEP ADIPOQ
48 11.74 TNF IL6 IL1B CXCL8
49 11.74 TNF IRAK4 IL6 IL1B CXCL8
50 11.71 TNF MEFV IRAK4 IL6 IL1B CXCL8

GO Terms for Pericarditis

Cellular components related to Pericarditis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.8 VTN TNFRSF1A TNF RETN PSG2 PRG4
2 extracellular space GO:0005615 9.47 VTN TNFRSF1A TNF RETN NPPB LEP

Biological processes related to Pericarditis according to GeneCards Suite gene sharing:

(show all 44)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 10.09 TNF IL6 IL1B IFNG CRP
2 cellular response to lipopolysaccharide GO:0071222 9.95 TNF IL6 IL1B CXCL8
3 immune response GO:0006955 9.95 VTN TNF PRG4 IL6 IL1B IFNG
4 positive regulation of protein phosphorylation GO:0001934 9.93 TNF LEP IL1B IFNG ADIPOQ
5 negative regulation of inflammatory response GO:0050728 9.92 TNFRSF1A MEFV ADIPOQ ADA
6 cytokine-mediated signaling pathway GO:0019221 9.91 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
7 positive regulation of inflammatory response GO:0050729 9.88 TNFRSF1A TNF IL1B IFNG
8 inflammatory response GO:0006954 9.87 TNFRSF1A TNF MEFV IL6 IL1B CXCL8
9 response to glucocorticoid GO:0051384 9.85 TNF IL6 ADIPOQ
10 positive regulation of T cell proliferation GO:0042102 9.84 LEP IL6 IL1B
11 glucose metabolic process GO:0006006 9.84 TNF LEP ADIPOQ
12 positive regulation of smooth muscle cell proliferation GO:0048661 9.83 TNF IRAK4 IL6
13 positive regulation of interleukin-6 production GO:0032755 9.83 TNF IL6 IL1B
14 regulation of insulin secretion GO:0050796 9.83 TNF LEP IL1B IFNG
15 negative regulation of fat cell differentiation GO:0045599 9.82 TNF IL6 ADIPOQ
16 positive regulation of phagocytosis GO:0050766 9.81 TNF IL1B IFNG
17 positive regulation of nitric oxide biosynthetic process GO:0045429 9.81 TNF IL1B IFNG
18 positive regulation of interleukin-6 secretion GO:2000778 9.8 TNF IL1B IFNG
19 positive regulation of JAK-STAT cascade GO:0046427 9.79 TNF LEP IL6
20 positive regulation of interleukin-8 production GO:0032757 9.78 TNF IL1B ADIPOQ
21 humoral immune response GO:0006959 9.78 TRAF3IP2 TNF IL6 IFNG
22 negative regulation of neurogenesis GO:0050768 9.77 TNF IL6 IL1B
23 positive regulation of glial cell proliferation GO:0060252 9.74 TNF IL6 IL1B
24 embryonic digestive tract development GO:0048566 9.73 TNF CXCL8 ADA
25 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.73 TRAF3IP2 TNFRSF1A TNF IRAK4 IL1B ADIPOQ
26 astrocyte activation GO:0048143 9.72 TNF IL1B IFNG
27 negative regulation of amyloid-beta clearance GO:1900222 9.69 TNF IFNG
28 negative regulation of synaptic transmission GO:0050805 9.69 IL1B ADIPOQ
29 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.69 TNF IL1B IFNG
30 positive regulation of interleukin-1 beta biosynthetic process GO:0050725 9.68 TNF IFNG
31 response to vitamin E GO:0033197 9.68 LEP ADA
32 interleukin-6 production GO:0032635 9.68 LEP IL1B
33 death-inducing signaling complex assembly GO:0071550 9.67 TNFRSF1A TNF
34 neutrophil mediated immunity GO:0002446 9.67 IRAK4 IL6
35 positive regulation of chemokine biosynthetic process GO:0045080 9.67 TNF IL1B IFNG
36 positive regulation of fever generation GO:0031622 9.64 TNF IL1B
37 positive regulation of neuroinflammatory response GO:0150078 9.63 TNF IL6 IL1B
38 sequestering of triglyceride GO:0030730 9.62 TNF IL1B
39 positive regulation of vitamin D biosynthetic process GO:0060557 9.59 TNF IFNG
40 positive regulation of nitrogen compound metabolic process GO:0051173 9.58 TNF IFNG
41 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.55 TNFRSF1A TNF LEP IL6 IFNG
42 regulation of establishment of endothelial barrier GO:1903140 9.54 TNFRSF1A TNF IL1B
43 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.13 TNF IL1B IFNG
44 negative regulation of lipid storage GO:0010888 8.92 TNF LEP IL6 CRP

Molecular functions related to Pericarditis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.26 RETN NPPB LEP ADIPOQ
2 cytokine activity GO:0005125 9.1 TNF IL6 IL1B IFNG CXCL8 ADIPOQ

Sources for Pericarditis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....